Need Help?

Genentech DevSci DAC

Contact Information

DevSci DAC d-list
devsci-dac-d@gene.com

Request Access

This DAC controls 16 datasets

Dataset ID	Description	Technology	Samples
EGAD50000000139	Source data for Figure.2A heatmap showing the gene expression across samples.		1213
EGAD50000000140	Cell annotation for single T and NK cells of PBMC collected from 113 patients, including UMAP coordinates and annotation.		1213
EGAD50000000141	Raw count matrix for CITE-seq data of PBMC collected from 113 patients.		1213
EGAD50000000142	Raw count matrix for scRNA-seq data of PBMC collected from 113 patients.		1213
EGAD50000000143	Clinical data for IMvigor130 cohort of patients, including treatment, response, survial time, and tumor PDL1-IC staining score.		1213
EGAD50000000144	Cell annotation for single CD8 T cells of PBMC collected from 113 patients, including UMAP coordinates and annotation		1213
EGAD50000000145	Cell annotation for single cells of PBMC collected from 113 patients, including UMAP coordinates and annotation.		1213
EGAD50000000195	Relevant clinical data for IMpower133 (GO30081) including treatment arm, overall survival, progression-free survival, best overall response, PD-L1 IHC, molecular subtype, and baseline clinical features.		271
EGAD50000000196	This dataset contains log2(TPM + 1) for 271 tumor samples profiled by RNA-seq for the entire transcriptome for samples originating from IMpower133 (GO30081).		271
EGAD50000000273	311 genes		1
EGAD50000000312	RNAsequencing from 271 samples.	Illumina NovaSeq 6000	271
EGAD50000000366	Source data of clinical study data corresponding to figures reported in the paper titled: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. PMID: 38418879 DOI: 10.1038/s41586-024-07121-9		293
EGAD50000000367	Source data of clinical study data corresponding to figures reported in the paper titled: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. PMID: 38418879 DOI: 10.1038/s41586-024-07121-9		293
EGAD50000000368	Source data of clinical study data corresponding to figures reported in the paper titled: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. PMID: 38418879 DOI: 10.1038/s41586-024-07121-9		293
EGAD50000000369	Matrix of counts from the serum peptide mass spec data from patients enrolled in the CITYSCAPE trial, and the sample annotation. Specifically, serum samples at C1D1, C2D1, C3D1, SCRN were collected from a total of 132 patients and subject to Mass Spec at Biognosys. The current study focused on patients who have samples at both C1D1 and C2D1 (n = 64 pairs). Associated metadata also included.		293
EGAD50000000370	Matrices of counts from single-cell RNA-seq data and single-cell CITE-seq data collected from 16 patients enrolled in GO30103 trial, and the cell level annotation. Specifically, PBMCs at C1D1, C1D15 (2 weeks after treatment), C2D1 (3 weeks after treatment) and C4D1 (9 weeks after treatment) were collected and subject to 10x Genomics protocol. Associated metadata also included.		293